DNAVSHCA• 28 Days (Normalized)
DNA vs HCA (Ginkgo Bioworks Holdings Inc. vs HCA Healthcare Inc.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $14.98
+115.85%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
HCA Performance $434.92
+8.18%
HCA Healthcare Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+107.67 pts
DNA outperforming by 107.67 percentage points
DNAHCA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA HCA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | DNA Price | DNA Gain (%) | HCA Price | HCA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $14.98 | +115.85% | $434.92 | +8.18% | +107.67% |
| Oct 02, 2026 | $12.35 | +77.95% | $426.69 | +6.14% | +71.81% |
| Oct 01, 2026 | $12.50 | +80.12% | $- | - | |
| Sep 30, 2026 | $12.83 | +84.87% | $430.43 | +7.07% | +77.80% |
| Sep 29, 2026 | $11.96 | +72.33% | $431.63 | +7.37% | +64.96% |
| Sep 28, 2026 | $10.46 | +50.72% | $432.60 | +7.61% | +43.11% |
| Sep 25, 2026 | $10.66 | +53.60% | $435.61 | +8.36% | +45.24% |
| Sep 24, 2026 | $10.25 | +47.69% | $423.48 | +5.34% | +42.35% |
| Sep 23, 2026 | $8.58 | +23.63% | $436.48 | +8.57% | +15.06% |
| Sep 22, 2026 | $9.37 | +35.01% | $438.12 | +8.98% | +26.03% |
| Sep 21, 2026 | $7.98 | +14.99% | $425.97 | +5.96% | +9.03% |
| Sep 18, 2026 | $7.88 | +13.54% | $427.71 | +6.39% | +7.15% |
| Sep 17, 2026 | $7.84 | +12.97% | $429.04 | +6.72% | +6.25% |
| Sep 16, 2026 | $7.06 | +1.73% | $430.43 | +7.07% | -5.34% |
| Sep 15, 2026 | $6.99 | +0.72% | $423.82 | +5.42% | -4.70% |
Page 1 of 2